Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

中止 医学 HBeAg 内科学 慢性肝炎 胃肠病学 乙型肝炎 抗病毒治疗 肝炎 乙型肝炎病毒 免疫学 病毒 乙型肝炎表面抗原
作者
George Papatheodoridis,Jiannis Vlachogiannakos,Εvangelos Cholongitas,Karsten Wursthorn,Christos Thomadakis,Giota Touloumi,Jörg Petersen
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:63 (5): 1481-1492 被引量:258
标识
DOI:10.1002/hep.28438
摘要

The possibility of safe discontinuation of therapy with nucleos(t)ide analogues (NAs) remains one of the most controversial topics in the management of chronic hepatitis B. Therefore, we systematically reviewed the existing data on NA discontinuation in this setting and tried to identify factors affecting the probability of posttherapy remission. A literature search was performed in order to identify all published studies including patients who discontinued NAs in virological remission (VR) and were followed for ≥12 months thereafter. Twenty-five studies with 1716 patients were included. The pooled rates of durable VR remission were 51.4%, 39.3%, and 38.2% at 12, 24, and 36 months, respectively, after NA discontinuation, being relatively higher in initially hepatitis B e antigen (HBeAg)-positive patients (62.5%, 53.4%, 51.5%) than HBeAg-negative patients (43.7%, 31.3%, 30.1%) (P = 0.064). The weighted probability of durable biochemical remission was 65.4%, being numerically higher in HBeAg-positive than HBeAg-negative patients (76.2% versus 56.7%, P = 0.130). The weighted probability of hepatitis B surface antigen loss was 2.0%. The rates of durable VR did not significantly differ according to the VR definition (hepatitis B virus DNA <200, < 2000, < 20,000 IU/mL) or duration of on-therapy VR in HBeAg-positive patients, but they were significantly higher in studies with HBeAg-negative patients and on-therapy VR > 24 than ≤ 24 months (VR at 12 months off-NAs: 75.0% versus 35.6%, P = 0.005). The weighted probability of durable HBeAg seroconversion was 91.9% and 88.0% at 12 and 24 months, respectively, after NA discontinuation without being affected by the duration of on-therapy VR or consolidation therapy (>6 months in all studies).Durable VR seems to be feasible in a substantial proportion of patients who discontinue long-term NA therapy; on-therapy VR > 24 months offers higher chances of off-NA VR in patients with HBeAg-negative chronic hepatitis B.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大橙子发布了新的文献求助10
1秒前
领导范儿应助科研通管家采纳,获得10
2秒前
量子星尘发布了新的文献求助10
6秒前
明钟达完成签到 ,获得积分10
14秒前
byyyy完成签到,获得积分10
17秒前
高高的哈密瓜完成签到 ,获得积分10
21秒前
Rondab应助橙汁采纳,获得10
24秒前
读书的时候完成签到,获得积分10
26秒前
颜云尔完成签到,获得积分10
37秒前
孤独雨梅完成签到,获得积分10
40秒前
woobinhua完成签到 ,获得积分10
40秒前
雪落你看不见完成签到,获得积分10
42秒前
十月天秤完成签到,获得积分0
43秒前
依文完成签到,获得积分20
43秒前
ymr完成签到 ,获得积分10
44秒前
哦哦哦完成签到 ,获得积分10
45秒前
jzmupyj完成签到,获得积分10
45秒前
大橙子发布了新的文献求助10
48秒前
xdlongchem完成签到,获得积分10
49秒前
量子星尘发布了新的文献求助10
51秒前
小梦完成签到,获得积分10
52秒前
xuhang完成签到,获得积分10
52秒前
ZSHAN完成签到,获得积分10
53秒前
美满的机器猫完成签到,获得积分10
56秒前
王小磊完成签到,获得积分10
1分钟前
谢花花完成签到 ,获得积分10
1分钟前
1分钟前
瓦罐完成签到 ,获得积分10
1分钟前
扁舟灬完成签到,获得积分10
1分钟前
Cpp完成签到 ,获得积分10
1分钟前
贤惠的老黑完成签到 ,获得积分10
1分钟前
ame1120发布了新的文献求助10
1分钟前
倦梦还完成签到,获得积分10
1分钟前
Sunrise完成签到,获得积分10
1分钟前
yyyy发布了新的文献求助10
1分钟前
自觉柠檬完成签到 ,获得积分10
1分钟前
ergatoid完成签到,获得积分10
1分钟前
Hao完成签到,获得积分10
1分钟前
月亮煮粥完成签到,获得积分10
1分钟前
欣欣完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022